Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
作者信息
Willson J K, Knuiman M W, Skeel R T, Wolter J M, Pandya K J, Falkson G, Chang Y C
出版信息
Cancer Treat Rep. 1986 Oct;70(10):1237-8.
PMID:3530452
Abstract
摘要
相似文献
1
Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.阿西维辛治疗晚期乳腺癌的II期临床试验：东部肿瘤协作组研究
Cancer Treat Rep. 1986 Oct;70(10):1237-8.
2
Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.阿西维辛治疗晚期乳腺癌的II期试验：一项癌症与白血病B组研究
Cancer Treat Rep. 1986 Oct;70(10):1247-8.
3
Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.阿西维辛治疗肺癌的II期评估：一项东南癌症研究组试验
Cancer Treat Rep. 1986 Aug;70(8):1031-2.
4
Phase II trial of acivicin in advanced metastatic breast cancer.
Cancer Treat Rep. 1983 Sep;67(9):843-4.
5
Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.阿西维辛治疗结直肠癌的II期研究：加拿大国立癌症研究所的一项研究
Cancer Treat Rep. 1984 Sep;68(9):1121-3.
6
Phase II study of acivicin in non-small cell lung cancer: a National Cancer Institute of Canada Study.
Cancer Treat Rep. 1986 Nov;70(11):1327-8.
7
Phase I study of acivicin in patients with advanced cancer.
Cancer Treat Rep. 1983 Jul-Aug;67(7-8):701-3.
8
Phase II trial of acivicin in malignant mesothelioma.
Cancer Treat Rep. 1987 May;71(5):545-6.
9
Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.阿西维辛用于晚期上皮性卵巢癌患者的II期试验。一项妇科肿瘤学组研究。
Invest New Drugs. 1986;4(1):49-52. doi: 10.1007/BF00172016.
10
Idarubicin in advanced breast cancer: a phase II study.
Cancer Treat Rep. 1986 Dec;70(12):1439-40.
Zotero 插件